FIELD: medicine.
SUBSTANCE: declared group of inventions refers to medicine and pharmaceutics and represents application of composition containing more than 90 wt. % norbixin, obtained by way of purification from Bixa orellana seed extract, for photoprotection of cells of retinal pigment epithelium (RPE) in mammals by administering to said mammal said composition in amount of 0.48 mg/kg of body weight to 48 mg/kg of body weight per day, and a composition containing more than 95 wt. % norbixin, obtained by purifying from a Bixa orellana extract, for use in photoprotection of cells of retinal pigment epithelium (RPE) in mammals.
EFFECT: declared group of inventions is highly effective for photoprotection of cells of retinal pigment epithelium (RPE) in mammals.
16 cl, 13 dwg, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF SIMULATING RETINAL PIGMENT EPITHELIUM ATROPHY | 2019 |
|
RU2727000C1 |
| DEMETHYLATION FOR TREATMENT OF EYE DISEASE | 2019 |
|
RU2804300C2 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF DRUSEN IN AGE-RELATED MACULAR DYSTROPHY | 2020 |
|
RU2750907C1 |
| BDNF-BASED (BRAIN-DERIVED NEUROTROPHIC FACTOR) OPHTHALMIC PREPARATIONS AND USING THEM | 2010 |
|
RU2564920C2 |
| METHOD OF STEM CELL TRANSPLANTATION IN RETINAL PIGMENT EPITHELIUM IN EXPERIMENT | 2018 |
|
RU2707264C1 |
| VECTOR, METHOD FOR TREATING CHOROIDITIS, METHOD FOR SELECTIVE EXPRESSION OF POLYNUCLEOTIDE | 2014 |
|
RU2723101C2 |
| METHOD OF TREATING "DRY" FORM OF AGE MACULAR DEGENERATION | 2008 |
|
RU2375016C1 |
| METHOD FOR SELECTING THERAPEUTIC APPROACH TO AGE-RELATED MACULAR DEGENERATION (AMD) | 2018 |
|
RU2707955C1 |
| GENE THERAPY | 2016 |
|
RU2740038C2 |
| AAV VECTORS | 2018 |
|
RU2793112C2 |
